Clear cell sarcoma (CCS) and gastrointestinal neuroectodermal tumors (GNETs) constitute rare and aggressive sarcomas that have posed significant diagnostic challenges over recent decades. CCS is ...

Investigators developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to ...

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...

Dr. Arun Singh, the director of the UCLA sarcoma medical oncology program, sat down with Daily Bruin contributor Donya Hassanshahi during Sarcoma Awareness Month to discuss his role in managing ...

A potential novel therapeutic target for invasive soft tissue sarcoma detected through tumor immune microenvironment and genetic profile analyses. This is an ASCO Meeting Abstract from the 2024 ASCO ...

The phase 1/2 SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced soft tissue sarcoma. The study investigators from City of Hope ...

NORFOLK, Va. (WAVY) — Sarcoma, one of the rarest cancers in the world, makes up just 1% of all adult cancer diagnoses, but it is widely recognized as the ‘forgotten cancer,’ putting emphasis on just ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 56-year-old man presented to the ED with 3 months of ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...